|
1 |
16 05 2025 |
DoP invites applications for production of 11 bulk drugs under PLI scheme |
Pharmabiz |
India |
|
2 |
16 05 2025 |
LUB asks Centre to extend deadline till 2026 end for implementing revised Schedule M for cos below Rs. 50 crore turnover |
Pharmabiz |
India |
|
3 |
16 05 2025 |
DTAB agrees to Prohibit 16 FDCs identified as Irrational |
Medical Dialogues |
India |
|
4 |
16 05 2025 |
USFDA clears Alembic Pharma Cardio drug Rivaroxaban, Launch excepted in next year |
Medical Dialogues |
India |
|
5 |
16 05 2025 |
After Baclofen , Now Gabapentin: Marksans Pharma arms bags another UK MHRA green light |
Medical Dialogues |
India |
|
6 |
16 05 2025 |
GSK to acquire Liver disease drug Efimosfermin for Up to USD 2 billion |
Medical Dialogues |
India |
|
7 |
16 05 2025 |
Generic pharma companies unlikely to be impacted by Trump's order to cut Rx drug prices: Report |
Economic Times |
India |
|
8 |
16 05 2025 |
KPRDO urges govt to exempt drug licenses from stamp duty |
Pharmabiz |
India |
|
9 |
15 05 2025 |
Pharmexcil initiates high-level discussions with key ASEAN nations to strengthen pharma trade |
Pharmabiz |
India |
|
10 |
15 05 2025 |
India invited to supply medicines to Chile’s National Health System |
Pharmabiz |
India |
|
11 |
15 05 2025 |
DTAB backs inclusion of name of authorised person of batch release on the license |
Pharmabiz |
India |
|
12 |
15 05 2025 |
Trump’s EO on MFN prescription drugs to strengthen adoption of generics & biosimilars |
Pharmabiz |
USA |
|
13 |
15 05 2025 |
Andhra Pradesh CM unveils Bharat Biotech arm Lumpy skin disease vaccine |
Medical Dialogues |
India |
|
14 |
15 05 2025 |
DCGI told to act against unapproved Antibiotics FDC's |
Medical Dialogues |
India |
|
15 |
15 05 2025 |
USFDA nod to Generic Therapeutic equivalent version of Janssen Pharma Haldol injection |
Medical Dialogues |
India |
|
16 |
15 05 2025 |
Unichem Labs Pithampur Facility gets USFDA EIR |
Medical Dialogues |
India |
|
17 |
15 05 2025 |
Pharma unit catches fire in Baddi, no casualties reported |
The Tribune India |
India |
|
18 |
14 05 2025 |
Telangana DCA issues advisory to public & stakeholders to check QR code to block entry of counterfeits |
Pharmabiz |
India |
|
19 |
14 05 2025 |
US govt order to have nil impact on Indian pharma players, says Cipla |
Business Standard |
India |
|
20 |
14 05 2025 |
Lupin launches Tolvaptan Tablets in the US with 180-day exclusivity |
Indian Pharma Post |
USA |
